Mitchell G. Scott, PhD

Professor, Department of Pathology & Immunology

Additional Titles

  • Co-Medical Director, Clinical Chemistry, Barnes-Jewish Hospital, St. Louis, MO
  • Medical Director, Point of Care Testing, Barnes-Jewish Hospital, St. Louis, MO


  • BA, Biology: Washington University School of Medicine, St. Louis, MO, 1974
  • MS, Biology: University of Missouri-St. Louis, St. Louis, MO, 1977
  • PhD, Immunology: Washington University School of Medicine, St. Louis, MO, 1982
  • Postdoctoral Fellow, Clinical Chemistry: Washington University School of Medicine, St. Louis, MO, 1984

Board Certifications

  • Diplomate, American Board of Clinical Chemistry, 1990


  • President, American Board of Clinical Chemistry, 1998-2000
  • American Association for Clinical Chemistry Award for Outstanding Contributions in Education, 2000
  • President, American Association for Clinical Chemistry, 2005
  • President, Academy of Clinical Laboratory Physicians and Scientists, 2009
  • American Association for Clinical Chemistry/Academy of Clinical Biochemistry, Trans-Atlantic Lectureship Award, 2010
  • Associate Editor, Clinical Chemistry, 2006 – Present

Clinical Interests

  • Glucose Monitoring in Hospitalized Patients
  • Cardiac Biomarkers
  • Clinical Trials of New Diagnostic Markers
  • General Clinical Chemistry
  • Point of Care Testing

Research Interests

I have been the principal investigator on over 60 industry-sponsored or investigator-initiated clinical studies of new laboratory tests and biomarkers.


Pub Med Search

Farnsworth CW, Bailey AL, Jaffe AS, Scott MG. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. Clin Biochem 2018;59:50-55.
Brown, JC, Samaha, E, Rao, S, Helwani, MA, Duma, A, Brown, F, Gage, BF, Miller, JP, Jaffe, AS, Apple, FS, Scott, MG, Nagele, P High-Sensitivity Cardiac Troponin T Improves the Diagnosis of Perioperative MI. Anesthesia and Analgesia 2017;125 (Nov):1455 – 62.
Zhang R, Isakow W, Kollef MH, Scott MG. Performance of a modern glucose meter in intensive care unit and general hospital inpatients: Three years of real-world paired meter and central laboratory results. Crit Care Med 2017;45:1509–1514.
Sudarshan S, Novak E, Hock K, Scott MG, Geltman, EM: Use of Biomarkers to Predict Readmission for Congestive Heart Failure. Am J Cardiol 2017:119:445-451.
Schindler EI, Szymanski JJ, Hock KG, Geltman EM, Scott MG: Short- and long-term biologic variability of Galectin-3 and other cardiac biomarkers in patients with stable heart failure and healthy adults. Clin Chem 2016;62:360-6.
Szymanski JJ, Otrock ZK, Patel K, Scott MG: Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer. Clin Chim Acta. 2016 Jan;453:190-3.
Wilen CB, Szymanski JJ, Hung S, Rajan A, Lavigne PM, Char DM, Geltman EM, Scott MG. Impact on patient management and outcome of switching between 2 contemporary sensitive cardiac troponin assays. Clin Chem 2015;61:870-876.
Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, Apple FS, Scott MG. High-sensitivity cardiac Troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after non-cardiac surgery. Am Heart J 2013;166:325-332.
Finfer S, Wernerman J, Preiser J-C, Cass T, Desaive T, Hovorka, Joseph JI, Kosiborod M, Krinsley J, Mackenzie I, Mesotten D, Schulz M, Scott MG, Slingerland R, Van den Berghe G and Van Herpe T. Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Critical Care 2013;17:229-40.
Scott MG, Bruns DE, Boyd JA, Sacks DB. Tight Glucose Control in the Intensive Care Unit: Are Glucose Meters up to the Task? Clin Chem 2009 55:18-20.

Julie Shafferkoetter

Lab Phone: 314-362-1475